Chronic pain is challenging to treat. Standard therapies have drawbacks. That's why there is growing interest in low dose naltrexone for fibromyalgia.
Some side effects are so scary that no one wants to talk about them. The FDA says there is no link between statins and ALS. But a new analysis of FDA data suggests there may be a connection.
Many people with a terminal illness are willing to take almost any risk to improve their odds. Will the new right to try bill passed by Congress help? What are the downsides?
Have you ever heard of low dose naltrexone (LDN)? We didn't think so. But this drug has been around for decades and it just might help people in pain.